Patrick M. Shea

Director Ejecutivo en Intrance Medical Systems, Inc. .

Health Technology

Perfil

Patrick M.
Shea is currently the Chief Executive Officer & Director at Intrance Medical Systems, Inc. He previously worked as a Director at OSI Pharmaceuticals, Inc.

Cargos activos de Patrick M. Shea

Empresas	Cargo	Inicio
Intrance Medical Systems, Inc. Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea.	Director Ejecutivo	13/05/2021

Todos los cargos activos de Patrick M. Shea

Antiguos cargos conocidos de Patrick M. Shea.

Empresas	Cargo	Fin
OSI PHARMACEUTICALS, INC.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Patrick M. Shea.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Patrick M. Shea.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
OSI Pharmaceuticals, Inc. OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY.	Health Technology
Intrance Medical Systems, Inc. Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea.	Health Technology